Cellular distribution of human tissue kallikreins: Immunohistochemical localization

Biological Chemistry

Volumn 387, Issue 6, 2006, Pages 653-663

  Petraki, Constantina D ^a   Papanastasiou, Panagiotis A ^b   Karavana, Vassiliki N ^a   Diamandis, Eleftherios P ^c,d  

^a EVANGELISMOS HOSPITAL   (Greece)

^b HYGEIA HOSPITAL   (Greece)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer biomarkers; Human tissue kallikreins; Immunohistochemistry; Prognostic markers; Serine proteases

Indexed keywords

BIOLOGICAL MARKER; SERINE PROTEINASE; TISSUE KALLIKREIN;

CELLULAR DISTRIBUTION; COLON CARCINOMA; CONFERENCE PAPER; CYTOPLASM; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; IMMUNOHISTOCHEMISTRY; KALLIKREIN KININ SYSTEM; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMATIC REVIEW; TISSUE SPECIFICITY; UROGENITAL TRACT TUMOR; UROTHELIUM;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; NEOPLASMS; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33745655393     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.084     Document Type: Conference Paper

References (106)

1. Abrahamsson, P.A., Lilja, H., Falkmer, S., and Wadstrom, L.B. (1988). Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 12, 39-46.
2. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
3. Bhoola, K., Ramsaroop, R., Plendl, J., Cassim, B., Dlamini, Z., and Naicker, S. (2001). Kallikrein and kinin receptor expression in inflammation and cancer. Biol. Chem. 382, 77-89.
4. Black, M.H., and Diamandis, E.P. (2000). The diagnostic and prognostic utility of prostate specific antigen for diseases of the breast. Breast Cancer Res. Treat. 59, 1-4.
5. Black, M.H., Magklara, A., Obiezu, C., Levesque, M.A., Sutherland, D.J., Tindall, D.J., Young, C.Y., Sauter, E.R., and Diamandis, E.P. (2000). Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumors and in normal breast secretions. Br. J. Cancer 82, 361-367.
6. Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
7. Cane, S., Bignotti, E., Bignotti, E., Bellone, S., Palmieri, M., De las Casas, L., Roman, J.J., Pecorelli, S., Cannon, M.J., O'Brien, T., and Santin, A.D. (2004). The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/neuropsin/ovasin) is highly overexpressed in cervical cancer. Am. J. Obstet. Gynecol. 190, 60-66.
8. Chang, A., Yousef, G.M., Jung, K., Rajpert-de Meyts, E., and Diamandis, E.P. (2001). Identification and molecular characterization of five novel kallikrein gene (KLK13; KLK14) splice variants: differential expression in the human testis and testicular cancer. Anticancer Res. 21, 3147-3152.
9. Chang, A., Yousef, G.M., Scorilas, A., Grass, L., Sismondi, P., Ponzone, R., and Diamandis, E.P. (2002). Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer. Br. J. Cancer 86, 1457-1464.
10. Chao, J., Sostek, M., Shimamoto, K., Bank, H.L., Bigelow, J., and Margolius, H.S. (1980). Kallikrein content of rat pancreatic acinar cells or islets by direct radioimmunoassay. Hoppe-Seyler's Z. Physiol. Chem. 361, 1805-1810.
11. Chu, T.M. (1997). Prostate-specific antigen and early detection of prostate cancer. Tumor Biol. 18, 123-134.
12. Clements, J.A. (1998). Current perspectives on the molecular biology of the renal tissue kallikrein gene and the related tissue kallikrein gene family. Biol. Res. 31, 151-159.
13. Clements, J. and Mukhtar, A. (1994). Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J. Clin. Endocrinol. Metab. 78, 1536-1539.
14. Clements, J. and Mukhtar, A. (1997). Tissue kallikrein and the bradyinin B2 receptor are expressed in endometrial and prostate cancers. Immunopharmacology 36, 217-220.
15. Clements, J., Mukhtar, A., Ehrlich, A., and Yap, B. (1994). Glandular kallikrein gene expression in the human uterus. Braz. J. Med. Biol. Res. 27, 1853-1863.
16. Clements, J.A., Mukhtar, A., Verity, K., Pullar, M., McNeill, P., Cummins, J., and Fuller, P.J. (1996). Kallikrein gene expression in human pituitary tissues. Clin. Endocrinol. 44, 223-231.
17. Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci. 41, 265-312.
18. Cumming, A.D., Walsh, T., Wojtacha, D., Fleming, S., Thomson, D., and Jenkins, D.A. (1994). Expression of tissue kallikrein in human kidney. Clin. Sci. (Lond.) 87, 5-11.
19. Darson, M.F., Pacelli, A., Roche, P., Rittenhouse, H.G., Wolfert, R.L., Young, C.Y., Klee, G.G., Tindall, D.J., and Bostwick, D.G. (1997). Human glandular kallikrein 2 (hK2) expression in prostate intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology 49, 857-862.
20. Darson, M.F., Pacelli, A., Roche, P., Rittenhouse, H.G., Wolfert, R.L., Saeid, M.S., Young, C.Y., Klee, G.G., Tindall, D.J., and Bostwick, D.G. (1999). Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases. Urology 53, 939-944.
21. Davidson, B., Xi, Z., Klokk, T.I., Trope, C.G., Dorum, A., Scheistroen, M., and Saatcioglu, F. (2005). Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions. Am. J. Clin. Pathol. 123, 360-368.
22. Dedio, J., Wiemer, G., Rutten, H., Dendorfer, A., Scholkens, B.A., Müller-Esterl, W., and Wohlfart, P. (2001). Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins. Biol. Chem. 382, 1483-1490.
23. Diamandis, E.P., and Yousef, G.M. (2001). Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev. Mol. Diagn. 1, 182-190.
24. Diamandis, E.P., Yousef, G.M., Clements, J., Ashworth, L.K., Yoshida, S., Egelrud, T., Nelson, P.S., Shiosaka, S., Little, S., Lilja, H., et al. (2000a). New nomenclature for the human tissue kallikrein gene family. Clin. Chem. 46, 1855-1858.
25. Diamandis, E.P., Yousef, G.M., Luo, L.Y., Magklara, A., and Obiezu, C.V. (2000b). The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab. 11, 54-60.
26. Diamandis, E.P., Yousef, G.M., Petraki, C., and Soosaipillai, A.R. (2000c). Human kallikrein 6 as a biomarker of Alzheimer's disease. Clin. Biochem. 33, 663-667.
27. Diamandis, E.P., Yousef, G.M., Soosaipillai, A.R., Grass, L., Porter, A., Little, S., and Sotiropoulou, G. (2000d). Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin. Biochem. 33, 369-375.
28. Diamandis, E.P., Okui, A., Mitsui, S., Luo, L.Y., Soosaipillai, A., Grass, L., Nakamura, T., Howarth, D.J., and Yamaguchi, N. (2002). Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res. 62, 295-300.
29. Dietl, T., Kruck, J., and Fritz, H. (1978). Localization of kallikrein in porcine pancreas and submandibular gland as revealed by the indirect immunofluorescence technique. Hoppe-Seyler's Z. Physiol. Chem. 359, 499-505.
30. Dong, Y., Kaushal, A., Bui, L., Chu, S., Fuller, P.J., Nicklin, J., Samaratunga, H., and Clements, J. (2001). Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin. Cancer Res. 7, 2363-2371.
31. Dong, Y., Kaushal, A., Brattsand, M., Nicklin, J., and Clements, J.A. (2003). Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin. Cancer Res. 9, 1710-1720.
32. Dong, Y., Bui, L.T., Odorico, D.M., Tan, O.L., Meyers, S.A., Samaratunga, H., Gardiner, R.A., and Clements, J.A. (2005). Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Endocr. Relat. Cancer 12, 875-889.
33. Gallee, M.P., Visser-de Jong, E., van der Korput, J.A., van der Kwast, T.H., ten Kate, F.J., Schroeder, F.H., and Trapman, J. (1990). Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens. Urol. Res. 18, 181-187.
34. Hoffman, B.R., Katsaros, D., Scorilas, A., Diamandis, P., Fracchioli, S., Rigault de la Longrais, I.A., Colgan, T., Puopolo, M., Giardina, G., Massobrio, M., and Diamandis, E.P. (2002). Immunofluorometric quantitation and histochemical localization of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br. J. Cancer 87, 763-771.
35. Jaffa, A.A., Chai, K.X., Chao, J., Chao, L., and Mayfield, R.K. (1992). Effects of diabetes and insulin on expression of kallikrein and rennin genes in the kidney. Kidney Int. 41, 789-795.
36. Jones, T.H., Figueroa, C.D., Smith, C., Cullen, D.R., and Bhoola, K.D. (1990). Characterization of a tissue kallikrein in human prolactin-secreting adenomas. J. Endocrinol. 124, 327-331.
37. Junes, M.J., Neuschatz, A.C., Bornstein, L.E., Naber, S.P., Band, V., and Wazer, D.E. (2003). Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery. Int. J. Radiat. Oncol. Biol. Phys. 56, 653-657.
38. Kim, H., Scorilas, A., Katsaros, D., Yousef, G.M., Massobrio, M., Fracchioli, S., Piccinno, R., Gordini, G., and Diamandis, E.P. (2001). Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br. J. Cancer 84, 643-650.
39. Kishi, T., Grass, L., Soosaipillai, A., Shimizu-Okabe, and Diamandis, E.P. (2003). Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin. Chem. 49, 87-96.
40. Komatsu, N., Takata, M., Otsuki, N., Toyama, T., Ohka, R., Takehara, K., and Saijoh, K. (2003). Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J. Invest. Dermatol. 121, 542-549.
41. Komatsu, N., Saijoh, K., Toyama, T., OhKa, R., Otsuki, N., Hussack, G., Takehara, K., and Diamandis, E.P. (2005). Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br. J. Dermatol. 153, 274-281.
42. Laxmikanthan, G., Blaber, S.I., Bernett, M.J., Scarisbrick, I.A., Aparecida Juliano, M., and Blaber, M. (2005). 1.70 Å X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding. Proteins 58, 802-814.
43. Little, S.P., Dixon, E.P., Morris, F., Buckley, W., Becker, G.W., Johnson, M., Dobbins, J.R., Wyrick, T., Miller, J.R., MacKellar, W., et al. (1997). Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J. Biol. Chem. 272, 25135-25142.
44. Luo, L.Y., Katsaros, D., Scorilas, A., Fracchioli, S., Piccinno, R., Rigault de la Longrais, I.A., Howarth, D.J.C., and Diamandis, E.P. (2001). Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin. Cancer Res. 7, 2372-2379.
45. Luo, L.Y., Diamandis, E.P., Look, M.P., Soosaipillai, A.P., and Foekens, J.A. (2002). Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance. Br. J. Cancer 86, 1790-1796.
46. Luo, L.Y., Yousef, G., and Diamandis, E.P. (2003). Human tissue kallikreins and testicular cancer. ARMIS 111, 225-233.
47. Magklara, A., Cheung, C.C., Asa, S.L., and Diamandis, E.P. (2000). Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland. Clin. Chim. Acta 300, 171-180.
48. Margolius, H.S., Horwitz, D., Pisano, J.J., and Keiser, H.R. (1974). Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ. Res. 35, 820-825.
49. Margolius, H.S. (1998). Kallikreins, kinins and cardiovascular diseases: a short review. Biol. Res. 31, 135-141.
50. McCormack, R.T., Rittenhouse, H.G., Finlay, J.A., Sokoloff, R.L., Wang, T.J., Wolfert, R.L., Lilja, H., and Oesterling, J. (1995). Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 45, 729-744.
51. Mitsui, S., Yamada, T., Okui, A., Kominami, K., Uemura, H., and Yamaguchi, N. (2000). A novel isoform of a kallikrein-like protease, TLSP/hippostatin (PRSS20), is expressed in the human brain and prostate. Biochem. Biophys. Res. Commun. 272, 205-211.
52. Mitsui, S., Okui, A., Uemura, H., Mizuno, T., Yamada, T., Yamamura, Y., and Yamaguchi, N. (2002). Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease. Ann. NY Acad. Sci. 977, 216-223.
53. Naicker, T., Khedun, S.M., Moodley, D., and Bhoola, K. (1997). Localisation of tissue kallikrein in the kidney of black African women with early onset pre-eclampsia: a pilot study. Immunopharmacology 36, 249-254.
54. Naicker, S., Naidoo, S., Ramsaroop, R., Moodley, D., and Bhoola, K. (1999). Tissue kallikrein and kinins in renal disease. Immunopharmacology 44, 183-192.
55. Obiezu, C.V., Katsaros, D., Massobrio, M., Scorilas, A., Yousef, G.M., Fracchioli, S., Rigault de la Longrais, I.A., Arisio, R., and Diamandis, E.P. (2001). Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clin. Cancer Res. 7, 2380-2386.
56. Obiezu, C.V., Soosaipillai, A., Jung, K., Stephan, C., Scorilas, A., Howarth, D.H., and Diamandis, E.P. (2002). Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. Clin. Chem. 48, 1232-1240.
57. Obiezu, C.V., Shan, S.J., Soosaipillai, A., Luo, L.Y., Grass, L., Sotiropoulou, G., Petraki, C.D., Papanastasiou, P.A., Levesque, M.A., and Diamandis, E.P. (2005). Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids. Clin. Chem. 51, 1432-1442.
58. ole-MoiYoi, O.K., Pinkus, G.S., Spragg, J., and Austen, K.F. (1979). Identification of human glandular kallikrein in the beta cell of the pancreas. N. Engl. J. Med. 300, 1289-1294.
59. Orstavik, T.B., Brandtzaeg, P., Nustad, K., and Pierce, J.V. (1980). Immunohistochemical localization of kallikrein in human pancreas and salivary glands. J. Histochem. Cytochem. 28, 557-562.
60. Orstavik, T.B., Brekke, I.B., Alumets, J., and Carretero, O.A. (1981). Kallikrein in rat pancreatic tissue after beta cell destruction or acinar cell atrophy. J. Histochem. Cytochem. 29, 1431-1436.
61. Petraki, C.D., Karavana, V.N., Skoufogiannis, P.T., Little, S.P., Howarth, D.J.C., Yousef, G.M., and Diamandis, E.P. (2001). The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues, as assessed by immunohistochemistry. J. Histochem. Cytochem. 49, 1431-1442.
62. Petraki, C.D., Karavana, V.N., Luo, L.Y., and Diamandis, E.P. (2002a). Human kallikrein 10 expression in normal tissues by immunohistochemistry. J. Histochem. Cytochem. 50, 1247-1261.
63. Petraki, C.D., Karavana, V.N., Revelos. K.I., Luo. L.Y., and Diamandis, E.P. (2002b). Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets. Histochem. J. 34, 313-322.
64. Petraki, C.D., Karavana, V.N., and Diamandis, E.P. (2003a). Human kallikrein 13 expression in normal tissues. An immunohistochemical study. J. Histochem. Cytochem. 51, 493-501.
65. Petraki, C.D., Papanastassiou, P.A., Gregorakis, A.K., Karavana, V.N., Luo, L.Y., and Diamandis, E.P. (2003b). Immunohistochemical localization of human kallikreins 6, 10, and 13 in benign and malignant prostatic tissues. Prostate Cancer Prostatic Dis. 6, 223-227.
66. Petraki, C.D., Gregorakis, A.K., Vaslamatzis, M.M., Papanastassiou, P., Yousef, G.M., and Diamandis, E.P. (2005). The immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Correlation with several prognostic factors. Tumor Biol. 27, 1-7.
67. Pinkus, G.S., Maier, M., Seldin, D.C., ole-MoiYoi, O.K., Austen, K.F., and Spragg, J. (1983). Immunohistochemical localization of glandular kallikrein in the endocrine and exocrine human pancreas. J. Histochem. Cytochem. 31, 1279-1288.
68. Pretlow, T.G., Pretlow, T.P., Yang, B., Kaetzel, C.S., Delmord, C.M., Kamis, S.M., Bodner, D.R., Kursh, E., Resnick, M.I., and Bradley, E.L. (1991). Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia. Int. J. Cancer 49, 645-649.
69. Rae, F., Bulmer, B., Nicol, D., and Clements, J. (1999). The human tissue kallikreins (KLK1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library. Immunopharmacology 45, 83-88.
70. Ramsaroop, R., Naicker, S., Naicker, T., Naidoo, S., and Bhoola, K.D. (1997). Tissue kallikrein and kinins in renal disease. Immunopharmacology 36, 255-261.
71. Rittenhouse, H.G., Finlay, J.A., Mikolajczyk, S.D., and Partin, A.W. (1998). Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci. 35, 275-368.
72. Seidah, N.G. and Chretien, M. (1999). Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive peptides. Brain Res. 848, 45-62.
73. Shigemasa, K., Tian, X., Gu, L., Tanimoto, H., Underwood, L.J., O'Brien, T.J., and Ohama, K. (2004). Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favourable prognosis in ovarian cancer. Oncol. Rep. 11, 1153-1159.
74. Shimizu-Okabe, C., Yousef, G.M., Diamandis, E.P., Yoshida, S., Shiosaka, S., and Fahnestock, M. (2001). Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport 12, 2747-2751.
75. Shvartsman, H.S., Lu, K.H., Lee, J., Lillie, J., Deavers, M.T., Clifford, S., Wolf, J.K., Mills, G.B., Bast, R.C., Gershenson, D.M., and Schmandt, R. (2003). Overexpression of kallikrein 10 in epithelial ovarian carcinomas. Gynecol. Oncol. 90, 44-50.
76. Siivola, P., Pettersson, K., Piironen, T., Lovgren, T., Lilja, H., and Bjartell, A. (2000). Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections. Urology 56, 682-688
77. Simmer, P.J. (2004). Kallikrein 4 is a secreted protein. Cancer Res. 64, 8481-8483.
78. Stenman, U.-H. (1999). New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease. Clin. Chem. 45, 753-754.
79. Stephan, C., Yousef, G.M., Scorilas, A., Jung, K., Jung, M., Kristiansen, G., Hauptmann, S., Bharaj, B.S., Nakamura, T., Loening, S.A., and Diamandis, E.P. (2003). Quantitative analysis of kallikrein 15 gene expression in prostate tissue. J. Urol. 169, 361-364.
80. Tanimoto, H., Underwood, L.J., Shigemasa, K., Yan Yan, M.S., Clarke, J., Parmley, T.H., and O'Brien, T.J. (1999). The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer 86, 2074-2782.
81. Terashima, H., Atomi, Y., Kuroda, A., Morioka, Y., Ikekita, M., Aoki, K., Kamada, M., Kizuki, K., and Moriya, H. (1989). Purification of human pancreatic kallikrein and organ-specificities of human glandular kallikrein [in Japanese]. Nippon Shokakibyo Gakkai Zasshi 86, 2556-2565.
82. Terayama, R., Bando, Y., Takahashi, T., and Yoshida, S. (2004). Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord. Glia 48, 91-101.
83. Tremblay, R.R., Deperthes, D., Tetu, B., and Dube, J.Y. (1997). Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors. Am. J. Pathol. 150, 455-459.
84. Uehara, S., Honjyo, K., Furukawa, S., Hirayama, A., and Sakamoto, W. (1989). Role of the kallikrein-kinin system in human pancreatitis. Adv. Exp. Med. Biol. 247B, 643-648.
85. Underwood, L.J., Tanimoto, H., Wang, Y., Shigemasa, K., Parmley, K., and O'Brien, T.J. (1999). Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res. 59, 4435-4439.
86. Vio, C.P., Roa, J.P., Silva, R., and Powers, C.A. (1990). Localization of immunoreactive glandular kallikrein in lactotrophs of the rat anterior pituitary. Neuroendocrinology 51, 10-14.
87. Williams, R.J., Henderson, L.M., Naidoo, Y., Cassim, B., Elson, C.J., and Bhoola, K.D. (1997). Immunocytochemical analysis of tissue kallikrein and the kinin moiety in rheumatoid synovial fluid neutrophils. Br. J. Rheumatol. 36, 420-425.
88. Wolf, W.C., Harley, R.A., Sluce, D., Chao, L., and Chao, J. (1999). Localization and expression of tissue kallikrein and kallistatin in human blood vessels. J. Histochem. Cytochem. 47, 221-228.
89. Xi, Z., Klokk, T.I., Korkmaz, K., Kurys, P., Elbi, C., Risberg, B., Danielsen, H., Loda, M., and Saatcioglu, F. (2004). Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res. 64, 2365-2370.
90. Yamanaka, H., He, X., Matsumoto, K., Shiosaka, S., and Yoshida, S. (1999). Protease M/neurosin mRNA is expressed in mature oligodendrocytes. Brain Res. Mol. Brain Res. 71, 217-224.
91. Yayama, K., Kunimatsu, N., Teranishi, Y., Takano, M., and Okamoto, H. (2003). Tissue kallikrein is synthesized and secreted by human vascular endothelial cells. Biochem. Biophys. Acta 1593, 231-238.
92. Yoi, O.O., Seldin, D.C., Spragg, J., Pinkus, G.S., and Austen, K.F. (1979). Sequential cleavage of proinsulin by human pancreatic kallikrein and a human pancreatic kininase. Proc. Natl. Acad. Sci. USA 76, 3612-3616.
93. Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184-204.
94. Yousef, G.M. and Diamandis, E.P. (2002). Human tissue kallikreins: a new enzymatic cascade pathway? Biol. Chem. 383, 1045-1057.
95. Yousef, G.M., Scorilas, A., Magklara, A., Soosaipillai, A., and Diamandis, E.P. (2000). The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation. Gene 254, 119-128.
96. Yousef, G.M., Magklara, A., Chang, A., Jung, K., Katsaros, D., and Diamandis, E.P. (2001). Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res. 61, 3425-3431.
97. Yousef, G.M., Borgono, C.A., Scorilas, A., Ponzone, R., Biglia, N., Iskander, L., Polymeris, M.E., Roagna, R., Sismondi, P., and Diamandis, E.P. (2002a). Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis. Br. J. Cancer 87, 1287-1293.
98. Yousef, G.M., Obiezu, C.V., Jung, K., Stephan, C., Scorilas, A., and Diamandis, E.P. (2002b). Differential expression of kallikrein gene 5 in cancerous and normal testicular tissues. Urology 60, 714-718.
99. Yousef, G.M., Scorilas, A., Chang, A., Rendl, L., Diamandis, M., Jung, K., and Diamandis, E.P. (2002c). Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. Prostate 51, 126-132.
100. Yousef, G.M., Scorilas, A., Kyriakopoulou, L.G., Rendl, L., Diamandis, M., Ponzone, R., Biglia, N., Gial, M., Roagna, R., Sismondi, P., and Diamandis, E.P. (2002d). Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin. Chem. 48, 1241-1250.
101. Yousef, G.M., Scorilas, A., Magklara, A., Memari, N., Ponzone, R., Sismondi, P., Biglia, N., Abd Ellatif, M., and Diamandis, E.P. (2002e). The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer. Br. J. Cancer 87, 1294-1300.
102. Yousef, G.M., Kishi, T., and Diamandis, E.P. (2003a). Role of kallikrein enzymes in the central nervous system. Clin. Chim. Acta 329, 1-8.
103. Yousef, G.M., Polymeris, M., Yacoub, G.M., Scorilas, A., Soosaipaillai, A., Popalis, C., Fracchioli, S., Katsaros, D., and Diamandis, E.P. (2003b). Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res. 63, 2223-2227.
104. Yousef, G.M., Scorilas, A., Katsaros, D., Fracchioli, S., Iskander, L., Borgono, C., Rigault de la Longrais, I.A., Puopolo, M., Massobrio, M., and Diamandis, E.P. (2003c). Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. J. Clin. Oncol. 21, 3119-3126.
105. Yousef, G.M., Scorilas, A., Nakamura, T., Ellatif, M.A., Ponzone, R., Biglia, N., Maggiorotto, F., Roagna, R., Sismondi, P., and Diamandis, E.P. (2003d). The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. Breast Cancer Res. Treat. 78, 149-158.
106. Yousef, G.M., Obiezu, C.V., Luo, L.Y., Magklara, A., Borgono, C.A., Kishi, T., Memari, N., Michael, P., Sidiropoulos, M., Kurlender, L., et al. (2005). Human tissue kallikreins: from gene structure to function and clinical applications. Adv. Clin. Chem. 39, 11-79.